Improved subthalamic nucleus depiction with quantitative susceptibility mapping.
about
Neuroimaging of Parkinson's disease: Expanding views.Technological advances in the surgical treatment of movement disorders.Quantitative susceptibility mapping (QSM): Decoding MRI data for a tissue magnetic biomarker.Overview of quantitative susceptibility mapping.The clinical utility of QSM: disease diagnosis, medical management, and surgical planning.Ultra-high field magnetic resonance imaging of the basal ganglia and related structuresComparison of magnetic resonance imaging sequences for depicting the subthalamic nucleus for deep brain stimulation.Patterns of Brain Iron Accumulation in Vascular Dementia and Alzheimer's Dementia Using Quantitative Susceptibility Mapping Imaging.Quantitative Susceptibility Mapping in Parkinson's Disease.Bone quantitative susceptibility mapping using a chemical species-specific R2* signal model with ultrashort and conventional echo data.Reproducibility of quantitative susceptibility mapping in the brain at two field strengths from two vendorsComparison of T2*-weighted and QSM contrasts in Parkinson's disease to visualize the STN with MRIRapid multi-orientation quantitative susceptibility mappingQuantitative Susceptibility Mapping: Contrast Mechanisms and Clinical Applications.Lateral Asymmetry and Spatial Difference of Iron Deposition in the Substantia Nigra of Patients with Parkinson Disease Measured with Quantitative Susceptibility MappingPhase-corrected bipolar gradients in multi-echo gradient-echo sequences for quantitative susceptibility mapping.Structure Prior Effects in Bayesian Approaches of Quantitative Susceptibility Mapping.Susceptibility-Based Neuroimaging: Standard Methods, Clinical Applications, and Future Directions.Clinical quantitative susceptibility mapping (QSM): Biometal imaging and its emerging roles in patient care.Potential of quantitative susceptibility mapping for detection of prostatic calcifications.Dentate nucleus iron deposition is a potential biomarker for tremor-dominant Parkinson's disease.Internal Structures of the Globus Pallidus in Patients with Parkinson's Disease: Evaluation with Phase Difference-enhanced Imaging.MEDI+0: Morphology enabled dipole inversion with automatic uniform cerebrospinal fluid zero reference for quantitative susceptibility mapping.Awake versus Asleep Deep Brain Stimulation Surgery: Technical Considerations and Critical Review of the Literature.Borders of STN determined by MRI versus the electrophysiological STN. A comparison using intraoperative CT.Internal structures of the globus pallidus in patients with Parkinson's disease: evaluation with quantitative susceptibility mapping (QSM).Can We Rely on Susceptibility-Weighted Imaging (SWI) for Subthalamic Nucleus Identification in Deep Brain Stimulation Surgery?Quantitative susceptibility mapping using single-shot echo-planar imaging.Reproducibility of R2 * and quantitative susceptibility mapping (QSM) reconstruction methods in the basal ganglia of healthy subjects.Region-specific disturbed iron distribution in early idiopathic Parkinson's disease measured by quantitative susceptibility mapping.Quantification of cerebral perfusion using dynamic quantitative susceptibility mapping.Susceptibility Sensitive Magnetic Resonance Imaging Displays Pallidofugal and Striatonigral Fiber Tracts.Visualizing the Human Subcortex Using Ultra-high Field Magnetic Resonance Imaging.
P2860
Q28387732-FE2D507B-3CA5-4A0D-9472-55CF44CF6805Q30652376-CE754791-E45A-4AF6-B441-104D3F4823ABQ30837513-1C426036-85C5-49F7-9832-E22017EE20B1Q31115799-06E94270-B698-4F91-9FB8-C56E86C98011Q31146333-AC98C2CD-3A5A-4584-9457-E2F31DFDECA9Q34454816-DD3814CD-6050-4444-91E5-6F72328343BCQ34947321-19055D16-D851-4B09-BA40-2372D927676CQ35927317-B94229F4-57D5-4614-B30C-AF429D309977Q36123740-B1287F7D-3B84-4412-A14F-E4B1BE3A1814Q36297808-111D2E77-21BC-4B28-AE2B-A2E9149A6A4AQ36322681-7B63501D-BF9D-4898-B836-B09F40E8EF79Q36350945-9CC400BD-2B38-4025-9F50-2A891C0883E3Q36405117-43645A2F-926A-4ECD-B89B-F06CAE6B63A6Q36526057-AB9129CA-DAB7-4D6C-9725-5110A58FD093Q36902028-5D709AE9-1EBC-4DF2-9311-0128F1156FA1Q36956619-F57D8886-757F-4415-A9FC-97007CCAC06DQ37549656-8DC8F22B-529E-4855-87AB-3EB6A23D7D26Q38659676-D0198AC9-7816-4413-9F34-51ED4EACE890Q39179797-1B15A6E5-E8F9-4579-BFA3-D0E819D1A036Q39600655-FF61669A-7F9F-4B08-B317-C53FE5822939Q39756769-06531767-FC97-4628-B8F3-5921B9CE68A5Q47134607-D06005EA-21AB-4F20-89B4-675CE097525CQ47576200-3FB15A09-ADD4-4C67-8FED-476BAAE46833Q47851736-49D643DD-877D-4D5F-827F-604DC77E8678Q47897129-551C72D1-90DF-4D3C-9433-2D1007599583Q48468980-6BAA2491-CAE6-488A-B7CF-9EE3BBED4888Q48564011-B5E4EBCD-D977-47BD-B242-C91C1AE76163Q48710615-EA84B636-0D87-4540-B7C7-AFFE2603CCFAQ48879914-C4DDB846-E435-4922-AE5B-AA8F9AA4A26AQ50438695-8AA47447-CD19-4874-B9F5-CDF738AE5448Q53069774-BF5501DB-E009-425A-A9E2-78F6BC84C414Q53656935-F1020E32-80F8-42A6-A945-FA552784F142Q55434373-B42F0D20-C688-438F-B09E-DC2103FCAA9B
P2860
Improved subthalamic nucleus depiction with quantitative susceptibility mapping.
description
2013 nî lūn-bûn
@nan
2013 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Improved subthalamic nucleus depiction with quantitative susceptibility mapping.
@ast
Improved subthalamic nucleus depiction with quantitative susceptibility mapping.
@en
type
label
Improved subthalamic nucleus depiction with quantitative susceptibility mapping.
@ast
Improved subthalamic nucleus depiction with quantitative susceptibility mapping.
@en
prefLabel
Improved subthalamic nucleus depiction with quantitative susceptibility mapping.
@ast
Improved subthalamic nucleus depiction with quantitative susceptibility mapping.
@en
P2093
P2860
P356
P1433
P1476
Improved subthalamic nucleus depiction with quantitative susceptibility mapping.
@en
P2093
A John Tsiouris
Michael G Kaplitt
Sarah Eskreis-Winkler
Weiwei Chen
P2860
P304
P356
10.1148/RADIOL.13121991
P407
P577
2013-05-14T00:00:00Z